Charles M. Baum - May 16, 2022 Form 3 Insider Report for Poseida Therapeutics, Inc. (PSTX)

Role
Director
Signature
/s/ Harry J. Leonhardt, Attorney-in-Fact
Stock symbol
PSTX
Transactions as of
May 16, 2022
Transactions value $
$0
Form type
3
Date filed
5/18/2022, 04:30 PM
Previous filing
Jan 18, 2022
Next filing
Jun 6, 2022

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.